SGN-30 (Anti-CD30 Monoclonal Antibody) Is Active and Well Tolerated in Patients with Refractory or Recurrent Systemic Anaplastic Large Cell Lymphoma (ALCL).
Year: 2005
Type: conference-abstract
Source: Blood
Authors: Andres Forero-Torres, Steven H. Bernstein, Ajay K. Gopal, Francine Foss, John P. Leonard, Joseph D. Rosenblatt, Nancy L. Bartlett, Bruce D. Cheson, Elliott Epner, Francisco J. Hernandez-Illizaliturri, Stephen J. Proctor, Pauline Brice, Harve Tilly, Corinne Haioun, Mats Jerkeman, Andre Bosly, Jennie M. Lorenz, Jeremy Barton
Institutions: University of Alabama at Birmingham, University of Rochester Medicine, University of Rochester, Seattle Cancer Care Alliance, University of Washington, Cornell University, Weill Cornell Medicine, University of Miami, Sylvester Comprehensive Cancer Center, Washington University in St. Louis, Georgetown University, Georgetown University Medical Center, Georgetown Lombardi Comprehensive Cancer Center, Oregon Health & Science University, Roswell Park Comprehensive Cancer Center, Royal Victoria Infirmary, Hôpital Saint-Louis, Centre Henri Becquerel, Centre Hospitalier Universitaire Henri-Mondor, Hôpitaux Universitaires Henri-Mondor, Lund University, Seagen (United States)
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4240101693